Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$0.4 - $0.65 $5,880 - $9,555
14,700 Added 41.14%
50,434 $26,000
Q1 2023

May 12, 2023

BUY
$0.56 - $1.02 $8,848 - $16,116
15,800 Added 79.26%
35,734 $22,000
Q4 2022

Feb 13, 2023

BUY
$0.77 - $24.8 $4,620 - $148,800
6,000 Added 43.06%
19,934 $18,000
Q3 2022

Nov 14, 2022

BUY
$0.82 - $41.8 $11,425 - $582,441
13,934 New
13,934 $15,000

About Biofrontera Inc.


  • Ticker BFRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 23,551,000
  • Market Cap $26.1M
  • Description
  • Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for phot...
More about BFRI
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.